Challenges associated and approaches for successful translation of nanomedicines into commercial products.
Technical Development, Bayer U.S. LLC, Shawnee, KS 66210, USA.
Vivek
V
Agrahari
Formulation Technology, Bayer Animal Health GmbH, Leverkusen 51368, Germany.
Praveen
P
Hiremath
D002626:Chemistry, Pharmaceutical / Q000331:legislation & jurisprudence; D016503:Drug Delivery Systems; D004345:Drug Industry; D004355:Drug Stability; D006801:Humans; D050997:Nanomedicine; D049329:Nanostructures / Q000737:chemistry*; D010316:Particle Size; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D011786:Quality Control; D013499:Surface Properties; D057170:Translational Research, Biomedical
D004364:Pharmaceutical Preparations
characterization; clinical challenges; commercialization; manufacturing scale-up; nanomedicine; nanopharmaceuticals; regulatory challenges; reproducibility